Health News Releases

October 30, 2024 14:40

Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54143515&newsitemid=20241029413584&lan=en-US&anchor=Parse+Biosciences&index=1&md

October 30, 2024 14:25

Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada Inc (Sumagen),

October 30, 2024 10:45

World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care

On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and

October 29, 2024 15:25

Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry

Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141438&newsitemid=20241028722622&lan=en-US&anchor=Boomi&index=1&md5=0797880acb2d3b33005b1492eb4e78bc)™, t

October 29, 2024 14:30

ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies,

October 29, 2024 13:50

BeiGene Mourns Death of Beloved Board Member Donald Glazer

BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54142605&newsitemid=20241028061544&lan=en-US&anchor=BeiGene&index=1&md5=91bcb3b9baea32c9e4fd8e1120f

October 28, 2024 10:40

LabGenomics USA Concludes Acquisition of IMD CLIA Labs

LabGenomics USA (https://www.labgusa.com/) has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This ac

October 27, 2024 13:30

Listing on the Tokyo Stock Exchange Prime Market

Rigaku Holdings Corporation, a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has completed its listing on the Tokyo Stock Excha

October 25, 2024 14:17

Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends

Galderma (SWX:GALD), the pure-play dermatology category leader, today announced a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region, which houses some of t

October 25, 2024 14:10

Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry

Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141433&newsitemid=20241024317066&lan=en-US&anchor=Boomi&index=1&md5=7d9b4c6f5795fffa95b058382b2d3658)™, t

October 25, 2024 11:38

Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first nine months of 2024, reporting record net sales and significant progress ac

October 24, 2024 10:00

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issue

October 23, 2024 14:45

ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation

ANANDA Scientific Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.anandascientific.com%2F&esheet=54138297&newsitemid=20241022571870&lan=en-US&anchor=ANANDA+Scientific+Inc.&

October 21, 2024 17:20

ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)

Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess™) for frown lines and crow’s feet after repeated injec

October 18, 2024 11:35

Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials

Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54136391&newsitemid=20241017355667&lan=en-US&anchor=Medidata&index=1&md5=d87912bb1e54e36a39a

October 17, 2024 14:45

Bio-Engineering Scale-Up Qorium Showcases Cultivated Leather Breakthrough, Signalling a Key Step Towards Commercialisation

Cultivated leather pioneer Qorium has released footage (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fvimeo.com%2F1017020585%3Fshare%3Dcopy%23t%3D0&esheet=54135213&newsitemid=20241

October 17, 2024 14:30

ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain

ANANDA (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fanandascientific.com%2F&esheet=54135042&newsitemid=20241015941899&lan=en-US&anchor=ANANDA&index=1&md5=44a7f5c1680156e5b97b89ec

October 17, 2024 14:25

Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024

Aster Guardians Global Nursing Award has today unveiled the top 10 finalists for 2024, one of whom will go on to win the grand title award of US $ 250,000. These 10 nurses have been shortlisted from a

October 14, 2024 16:00

Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA

Dong-A ST (http://en.donga-st.com/Main.da) (President/CEO Jae-Hun Jung, KRX: 170900) announced on October 11 that Imuldosa™ (usteki-numab-srlf/DMB-3115), a biosimilar referencing Stelara®, has won U.S

October 09, 2024 14:10

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

Avania (https://www.avaniaclinical.com/), the leading, global medical technology contract research organization (CRO) and advisory services partner, today announced its acquisition of Anagram (https:/

October 09, 2024 12:25

EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA

Invivoscribe is excited to announce that their CE-2797 IVD certified LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI (Netherlands) and the EMA to aid in the selection of individuals in th

October 08, 2024 08:37

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

GE HealthCare (Nasdaq: GEHC) has today announced the completion of its Phase I clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contras

October 04, 2024 16:50

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nado

October 02, 2024 13:45

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crownbio.com%2F&esheet=54128719&newsitemid=20241001076209&lan=en-US&anchor=Crown+Bioscience&index=1&md5=d0a4aa1a